NovoMedix Presents New Preclinical Data on NMX2 at the 2022

/PRNewswire/ -- NovoMedix, LLC ("NovoMedix"), a biotechnology company developing novel, multi-pathway modulators for fibrosis and cancer, today announced the...

Related Keywords

Illinois , United States , San Diego , California , Chicago , American , Cathy Swindlehurst , American Heart Association Scientific Session , Linkedin , Prnewswire Novomedix , Heart Association Scientific Session , Improves Metabolic Parameters , Protects Cardiomyocytes Against Ischemic , Novomedix ,